Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology

Campi R., Brookman-May S. D., Subiela Henriquez J. D., AKDOĞAN B., Brausi M., Klatte T., ...Daha Fazla

EUROPEAN UROLOGY FOCUS, cilt.5, sa.6, ss.1029-1057, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 5 Sayı: 6
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.euf.2018.04.001
  • Dergi Adı: EUROPEAN UROLOGY FOCUS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1029-1057
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Context: To date, established risk factors for prostate cancer (PCa) are limited to age, race, family history, and certain genetic polymorphisms. Despite great research efforts, available evidence on potentially modifiable risk factors is conflicting. Moreover, most studies on PCa risk factors did not consider the impact of prostate-specific antigen (PSA) testing on PCa diagnosis.